Craig J. Breslauer, M.D.
When advanced-stage arthritis starts to affect the big toe joint, it can hinder our ability to use the foot efficiently and limit our sporting, social and even everyday endeavors. In fact, the most frequent site of osteoarthritis (OA) in the forefoot is in the first metatarsophalangeal (MTP) joint, which is reported to affect one in 45 Americans over the age of 50.
Cartiva, a breakthrough new synthetic cartilage implant (SCI), is changing the game for toe arthritis sufferers. Recently, Craig J. Breslauer, DPM, FACFAS, CWS, a board-certified podiatrist at South Florida Orthopaedics & Sports Medicine, became the first physician in the state to perform the Cartiva implant surgery.
Until now, the “gold standard” for patients with arthritis in the big toe joint was fusion surgery, which caused a complete loss of mobility in the great toe joint. Remarkably, the Cartiva SCI is now allowing patients to recover full function of the foot with faster recovery times.